We are delighted to announce that LimestoneGrey has been named a finalist in the prestigious One Nucleus Awards (2026), a recognition that highlights their specialist expertise in supporting the UK’s life sciences, biotech and medtech sectors.
Being shortlisted by One Nucleus, one of the leading life sciences and healthcare membership organisations, is a significant milestone for their firm and reflects the impact of their work within one of the UK’s most innovative and research-intensive industries.
Recognising Excellence in the Life Sciences Community
The One Nucleus Awards celebrate organisations that demonstrate innovation, impact and excellence across the life sciences ecosystem. The awards bring together pioneering biotech companies, cutting-edge med-tech developers, life sciences innovators and the professional advisers who support them.
To be recognised as a finalist in the Most Innovative Professional Services Company of the Year category places LimestoneGrey alongside some of the most exciting and forward-thinking organisations in the sector.
For them, this recognition is particularly meaningful because life sciences is not just a market they operate in, it is a community they actively support and understand deeply.
Matthew Jones, Managing Director comments
“The life sciences sector presents unique technical, regulatory and scientific complexities. Preparing an R&D tax claim in this space requires more than basic compliance knowledge, it requires a genuine understanding.
We are fortunate to work closely with founders, CTOs, CSOs and laboratory leads from companies striving to make a genuine difference. Our role is to ensure that R&D tax claims clearly articulate the underlying scientific or technological advance being pursued, rather than focusing solely on commercial objectives or market outcomes.
We would like to congratulate all the shortlisted companies and thank our clients and partners who continue to place their trust in LimestoneGrey. Being named a One Nucleus Awards finalist reflects our commitment to technical excellence and our deep understanding of R&D in this space.
The UK life sciences sector remains one of the most dynamic and globally competitive industries, and we are proud to play a role in supporting the innovators developing new diagnostics, therapies, technologies and platforms that improve lives.
We are looking forward to celebrating on 19th March in London.”
Article provided by LimestoneGrey. Contact email: [email protected]
